Author

S. Mereiter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

J. M. Penninger· 3 shared T. Oliveira· 3 shared D. Hoffmann· 2 shared G. Jonsson· 2 shared J. Helm· 2 shared J. Stadlmann· 2 shared A. Gattinger· 1 shared A. Muenster-Kuehnel· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

J. M. Penninger

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CLEC18A interacts with sulfated GAGs and controls clear cell renal cell carcinoma progression

G. Jonsson, M. Hofmann, S. Mereiter, L. Hartley-Tassell, I. Sakic, T. Oliveira, D. Hoffmann, M. Novatchkova, A. Schleiffer, J. M. Penninger

This study identifies CLEC18A as a regulator of clear cell renal cell carcinoma progression by interacting with sulfated GAGs and shows its expression is linked to improved patient survival.

bioRxiv · Jul 8, 2024Cancer Biology

Tumor sialylation controls effective anti-cancer immunity in breast cancer

S. Mereiter, G. Jonsson, T. Oliveira, J. Helm, D. Hoffmann, M. Abeln, A.-K. Jochum, W. Jochum, M. J. Kellner, M. Feith, V. Tkalec, K. Wasilewska, J. Jiao, L. Emsenhuber, F. Holstein, , J. M. Penninger

This study shows that tumor sialylation suppresses anti-cancer immunity in breast cancer by altering immune cell interactions and checkpoint ligands, and that inhibiting sialylation enhances immune response and therapy effectiveness.

bioRxiv · Sep 20, 2023 · PreprintCancer Biology

Non-targeted isomer-sensitive N-glycome analysis reveals new layers of organ-specific diversity in mice.

J. Helm, S. Mereiter, T. Oliveira, A. Gattinger, D. M. Markovitz, J. M. Penninger, F. Altmann, J. Stadlmann

The paper presents a method for analyzing N-glycome diversity in mice tissues, revealing tissue-specific glycosylation patterns and non-canonical structures.

bioRxiv · Sep 19, 2022 · PreprintBiochemistry